MGTX - MeiraGTx Holdings plc Ordinary Shares

Day 1m 10m 60m PreMarket Market AfterHours Gap
7.43 0.0 (0.0%) 0.0 (0.0%) 0.0 (0.0%) -0.01 (-0.14%) --- 0.0 (0.0%) 0.0 (0.0%) 0.0 (0.0%)

MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.48
Diluted EPS:
-0.48
Basic P/E:
-15.479
Diluted P/E:
-15.479
RSI(14) 1m:
49.93
VWAP:
7.43
RVol:

Events

Period Kind Movement Occurred At

Related News